Clinical Trials In Washington

Discover hundreds of clinical trials in Washington.
Search clinical trials in Washington by city, condition or phase.

e.g. Respiratory Diseases

Washington•Healthy volunteers: No

Filter results

Results: 1,661

Longitudinal Study of the Porphyrias

Recruiting

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Seattle, Birmingham, Los Angeles, San Franciscoshow 11 more

Code:

NCT01561157

Conditions

Acute Porphyrias

Cutaneous Porphyrias

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

AveXis, Inc.

Location:

Tacoma, Seattle, Phoenix, Little Rockshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

Recruiting

Phase 1

Sponsor:

Viking Therapeutics, Inc.

Location:

Seattle, Palo Alto, Gainesville, Baltimore

Code:

NCT04973657

Conditions

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

VK0214

Placebo

Effectiveness of Frontal Plane Adaptability in a Novel Foot Prosthesis

Recruiting

Sponsor:

University of Washington

Location:

Seattle, Tampa, Mount Sterling

Code:

NCT06214026

Conditions

Amputation

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

META-Arc foot locked

META-Arc foot unlocked

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Recruiting

Phase 3

Sponsor:

Dermavant Sciences, Inc.

Location:

Spokane, Rogers, Fountain Valley, Rancho Santa Margaritashow 7 more

Code:

NCT05172726

Conditions

Plaque Psoriasis

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

tapinarof cream, 1%

Study to Evaluate the Effects of Oral NMRA 335140 Versus Placebo in Participants With Major Depressive Disorder

Recruiting

Phase 3

Sponsor:

Neumora Therapeutics, Inc.

Location:

Everett, Bellevue, Huntsville, Phoenixshow 55 more

Code:

NCT06029426

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NMRA 335140

Placebo

Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19

Recruiting

Phase 3

Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Location:

Spokane, Phoenix, High Point, Philadelphiashow 1 more

Code:

NCT04935476

Conditions

COVID-19

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Dapsone 85 mg PO BID

Placebo 85 mg PO BID

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

Recruiting

Phase 3

Sponsor:

DBV Technologies

Location:

Seattle, Birmingham, Tucson, Little Rockshow 41 more

Code:

NCT05741476

Conditions

Allergy, Peanut

Eligibility Criteria

Sex: All

Age: 4 - 7

Healthy Volunteers: Not accepted

Interventions

DBV712

Placebo

EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy

Recruiting

Phase 2

Sponsor:

James P. Rathmell, MD

Location:

Seattle, San Diego, Clermont, Gainesvilleshow 16 more

Code:

NCT05476276

Conditions

Painful Diabetic Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ISA specific

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

Phase 3

Sponsor:

NRG Oncology

Location:

Vancouver, Seattle, Little Rock, Anaheimshow 191 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Photon Beam Radiation Therapy

Quality-of-Life Assessment

Questionnaire Administration

Temozolomide

Popular cities in Washington

Seattle

e.g. Respiratory Diseases

Washington•Healthy volunteers: No

Filter results

Results: 1,661

Longitudinal Study of the Porphyrias

Recruiting

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Seattle, Birmingham, Los Angeles, San Franciscoshow 11 more

Code:

NCT01561157

Conditions

Acute Porphyrias

Cutaneous Porphyrias

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

AveXis, Inc.

Location:

Tacoma, Seattle, Phoenix, Little Rockshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

Recruiting

Phase 1

Sponsor:

Viking Therapeutics, Inc.

Location:

Seattle, Palo Alto, Gainesville, Baltimore

Code:

NCT04973657

Conditions

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

VK0214

Placebo

Effectiveness of Frontal Plane Adaptability in a Novel Foot Prosthesis

Recruiting

Sponsor:

University of Washington

Location:

Seattle, Tampa, Mount Sterling

Code:

NCT06214026

Conditions

Amputation

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

META-Arc foot locked

META-Arc foot unlocked

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Recruiting

Phase 3

Sponsor:

Dermavant Sciences, Inc.

Location:

Spokane, Rogers, Fountain Valley, Rancho Santa Margaritashow 7 more

Code:

NCT05172726

Conditions

Plaque Psoriasis

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

tapinarof cream, 1%

Study to Evaluate the Effects of Oral NMRA 335140 Versus Placebo in Participants With Major Depressive Disorder

Recruiting

Phase 3

Sponsor:

Neumora Therapeutics, Inc.

Location:

Everett, Bellevue, Huntsville, Phoenixshow 55 more

Code:

NCT06029426

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NMRA 335140

Placebo

Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19

Recruiting

Phase 3

Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Location:

Spokane, Phoenix, High Point, Philadelphiashow 1 more

Code:

NCT04935476

Conditions

COVID-19

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Dapsone 85 mg PO BID

Placebo 85 mg PO BID

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

Recruiting

Phase 3

Sponsor:

DBV Technologies

Location:

Seattle, Birmingham, Tucson, Little Rockshow 41 more

Code:

NCT05741476

Conditions

Allergy, Peanut

Eligibility Criteria

Sex: All

Age: 4 - 7

Healthy Volunteers: Not accepted

Interventions

DBV712

Placebo

EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy

Recruiting

Phase 2

Sponsor:

James P. Rathmell, MD

Location:

Seattle, San Diego, Clermont, Gainesvilleshow 16 more

Code:

NCT05476276

Conditions

Painful Diabetic Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ISA specific

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

Phase 3

Sponsor:

NRG Oncology

Location:

Vancouver, Seattle, Little Rock, Anaheimshow 191 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Photon Beam Radiation Therapy

Quality-of-Life Assessment

Questionnaire Administration

Temozolomide